Brokers Set Expectations for ESPR FY2027 Earnings
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities researchers at Zacks Research issued their FY2027 earnings per share (EPS) estimates for shares of Esperion Therapeutics in a research note issued on Tuesday, March 25th. Zacks Research analyst K. Das forecasts that the biopharmaceutical company will post earnings per share of $0.06 for the year. […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities researchers at Zacks Research issued their FY2027 earnings per share (EPS) estimates for shares of Esperion Therapeutics in a research note issued on Tuesday, March 25th. Zacks Research analyst K. Das forecasts that the biopharmaceutical company will post earnings per share of $0.06 for the year. […]
